CN103494904B - One treats neurasthenic Chinese medicine composition - Google Patents

One treats neurasthenic Chinese medicine composition Download PDF

Info

Publication number
CN103494904B
CN103494904B CN201310467243.1A CN201310467243A CN103494904B CN 103494904 B CN103494904 B CN 103494904B CN 201310467243 A CN201310467243 A CN 201310467243A CN 103494904 B CN103494904 B CN 103494904B
Authority
CN
China
Prior art keywords
fructus
parts
chinese medicine
medicine composition
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310467243.1A
Other languages
Chinese (zh)
Other versions
CN103494904A (en
Inventor
陈明玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310467243.1A priority Critical patent/CN103494904B/en
Publication of CN103494904A publication Critical patent/CN103494904A/en
Application granted granted Critical
Publication of CN103494904B publication Critical patent/CN103494904B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses one and treat neurasthenic Chinese medicine composition.The traditional Chinese medical science is thought, neurasthenia belongs to " being insomnia ", " cardiopalmus ", " melancholia ", " deficient ", " seminal emission ", the category such as " sexual impotence ", how to be hindered by feelings will, after spiritual hypertonicity or serious disease prolonged illness caused by visceral dysfunction.The present invention selects to have nourishing the liver and kidney, soothing liver-QI for relieving depression, spleen invigorating is regulated the flow of vital energy, replenishing blood for nourishing heart, sedate are calmed the nerves Chinese medicine Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.), Rhizoma et radix valerianae, Lignum Poria, Fructus sarcococcae ruscifoliae, Fructus Rubi obcordati, Herba Crotalariae Ferrugineae, Fructus Akebiae, pulvis ferri (ferrosic oxide), Fructus Melodini Henryi, Herba Ainsliaeae Glabrae, Placenta Hominis, Radix Glycyrrhizae, be brewed into soup and take orally, through clinical observation, total effective rate reaches 92%, and without obvious toxic and side effects.

Description

One treats neurasthenic Chinese medicine composition
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to one and treat neurasthenic Chinese medicine composition.
Background technology
Neurasthenia is a kind of based on brain and the weak neurosis of somatic function, and to be easy to excited, being easy to again tired is feature, often with the physiological dysfunction symptom such as emotional symptoms and muscle tone pain, sleep disorder such as anxiety, worry, irritability.Clinical manifestation is that patient is often sleepy, sleepy, weak, drowsiness for daytime, and night then has a sleepless night, dreaminess, loses the excitement of normal person and suppression temporal regularity.There are some researches show, work, study hypertonicity are acted hurriedly in a messy situation, and have a rest and sleep and be irregular, operating pressure is large, and health is in sub-health state and emotional instability etc., is to cause neurasthenic main cause.Current western medical treatment neurasthenia mainly relies on the hypnotic sedative dose of treatments such as stable, but these medicines existing defects in safety and dependency, easy addiction, drug resistance, side effect is larger, unsuitable long-term taking.I finds through clinical observation for many years, utilizes treatment by Chinese herbs neurasthenia to have good curative effect.
Summary of the invention
The object of this invention is to provide one and treat neurasthenic Chinese medicine composition.The traditional Chinese medical science is thought, neurasthenia belongs to " being insomnia ", " cardiopalmus ", " melancholia ", " deficient ", " seminal emission ", the category such as " sexual impotence ", how to be hindered by feelings will, after spiritual hypertonicity or serious disease prolonged illness caused by visceral dysfunction.
The object of the invention is to be achieved through the following technical solutions, the neurasthenic Chinese medicine composition of this treatment is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
Preferred: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8 parts, Rhizoma et radix valerianae 9 parts, Lignum Poria 9 parts, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8 parts, Herba Crotalariae Ferrugineae 9 parts, Fructus Akebiae 8 parts, pulvis ferri (ferrosic oxide) 9.5 parts, Fructus Melodini Henryi 12 parts, Herba Ainsliaeae Glabrae 12 parts, Placenta Hominis 12 parts, 8 parts, Radix Glycyrrhizae.
Preparation method: make decoction by traditional preparation method decocting.
Fang Zhong: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.): tranquillizing and allaying excitement; Rhizoma et radix valerianae: tranquilizing by nourishing the heart, regulate the flow of vital energy, promoting blood circulation and stopping pain; Lignum Poria, Fructus sarcococcae ruscifoliae: nourishing the liver is calmed the nerves; Fructus Rubi obcordati: the kidney invigorating arresting seminal emission; Herba Crotalariae Ferrugineae: gas of astringing the lung, spleen reinforcing kidney; Fructus Akebiae: liver-smoothing, qi-regulating, promoting blood circulation and stopping pain; Pulvis ferri (ferrosic oxide): checking hyperfunction of the liver for relieving convulsion, calm, enrich blood; Fructus Melodini Henryi, Herba Ainsliaeae Glabrae: with blood dissipating blood stasis, yin nourishing; Placenta Hominis: benefiting QI and nourishing blood, the kidney warming mend essence; Radix Glycyrrhizae: in QI invigorating benefit, coordinating the actions of various ingredients in a prescription.
Clinical data
1. 50 routine patients selected by physical data are the neurastheniac of my Out-patient Department and hospitalization, meet the diagnostic criteria that CCMD mono-2-R related neurological is weak, and are difficult to adhere to normal work, studying and living.According to being admitted to hospital, sequencing is divided into two groups at random.Treatment group 25 example, man 15 example, female 10 example; 16 ~ 46 years old age, average 25.3 years old; The course of disease is the shortest 5 months, the longest 4.2 years, average 1.3 ± 0.8 years.Matched group 25 example, man 13 example, female 12 example; Age 16-45 year, average 23.6 years old; The course of disease is the shortest 6 months, the longest 3.6 years, average 1.2 ± 0.65 years.Two groups of data compare without significant difference.Have than can property.
2. all cases of diagnostic criteria are all diagnosed with reference to diagnostic criteria neurasthenic in " neurological ".
3. Therapeutic Method matched group patient gives 1. general treatment: give estazolam 2mg, every day 3 times, and insomnia severe one adds to 4 ~ 6mg night; Oryzanol 20mg, every day 3 times; Piracetam 0.8g, every day 3 times; Depressed person is accompanied to give doxepin 25mg, every day 3 times.2. psychotherapy: the method adopting individual psychotherapy, 1 time weekly, explains the neurasthenic cause of disease, character and prognosis to patient repeatedly, analyze the reason of therapeutic effect difference in the past, by curing advising by citing one's own experience of case, patient is freed one's mind of apprehensions, build confidence, positive partner treatment.Church patient does progressive relaxation training, and every day is 1-2 time.Treatment group adds on matched group basis uses new prescription: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, Fructus sarcococcae ruscifoliae 10 parts of g, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, Placenta Hominis 12 parts of g, Radix Glycyrrhizae 8g, decocting becomes juice, instructions about how to take medicine: day potion, decoction being taken warmly at twice, serveing on 7 days was 1 course for the treatment of.
4. criterion of therapeutical effect recovery from illness: clinical symptom disappearance, does not affect normal work and study.Effective: sleep quality improves, appetite increases, and the diseases such as headache, dizziness, fatigue and weak are taken a turn for the better, hypermnesia.Effective: above-mentioned symptom makes moderate progress.Invalid: before and after treatment, clinical symptoms is unchanged.
5. after therapeutic outcome two groups of patients all treat 4 courses for the treatment of, treatment group total effective rate 92% is better than 68% of matched group, and difference has statistical significance (P < 0.05), and concrete Comparison of therapeutic data are in table 1.
Table 1 liang group Comparison of therapeutic
6. untoward reaction: do not find obvious adverse reaction.
Detailed description of the invention
Embodiment one: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8g, Rhizoma et radix valerianae 9g, Lignum Poria 9g, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8g, Herba Crotalariae Ferrugineae 9g, Fructus Akebiae 8g, pulvis ferri (ferrosic oxide) 9.5g, Fructus Melodini Henryi 12g, Herba Ainsliaeae Glabrae 12g, Placenta Hominis 12 parts of g, Radix Glycyrrhizae 8g, makes decoction by traditional preparation method decocting.
Embodiment two: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7g, Rhizoma et radix valerianae 8g, Lignum Poria 6g, Fructus sarcococcae ruscifoliae 8g, Fructus Rubi obcordati 7g, Herba Crotalariae Ferrugineae 7g, Fructus Akebiae 7g, pulvis ferri (ferrosic oxide) 7g, Fructus Melodini Henryi 10g, Herba Ainsliaeae Glabrae 10, Placenta Hominis 10-g, Radix Glycyrrhizae 6g, makes decoction by traditional preparation method decocting.
Embodiment three: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 9g, Rhizoma et radix valerianae 10g, Lignum Poria 12g, Fructus sarcococcae ruscifoliae 12g, Fructus Rubi obcordati 9g, Herba Crotalariae Ferrugineae 11g, Fructus Akebiae 9g, pulvis ferri (ferrosic oxide) 12g, Fructus Melodini Henryi 14g, Herba Ainsliaeae Glabrae 14g, Placenta Hominis 14g, Radix Glycyrrhizae 10g, makes decoction by traditional preparation method decocting.

Claims (2)

1. treat a neurasthenic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 7-9 part, Rhizoma et radix valerianae 8-10 part, Lignum Poria 6-12 part, Fructus sarcococcae ruscifoliae 8-12 part, Fructus Rubi obcordati 7-9 part, Herba Crotalariae Ferrugineae 7-11 part, Fructus Akebiae 7-9 part, pulvis ferri (ferrosic oxide) 7-12 part, Fructus Melodini Henryi 10-14 part, Herba Ainsliaeae Glabrae 10-14 part, Placenta Hominis 10-14 part, Radix Glycyrrhizae 6-10 part.
2. one according to claim 1 treats neurasthenic Chinese medicine composition, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Plagiopus oederi (Brid.) Limpr.(Polytrichum annotinum L.) 8 parts, Rhizoma et radix valerianae 9 parts, Lignum Poria 9 parts, Fructus sarcococcae ruscifoliae 10 parts, Fructus Rubi obcordati 8 parts, Herba Crotalariae Ferrugineae 9 parts, Fructus Akebiae 8 parts, pulvis ferri (ferrosic oxide) 9.5 parts, Fructus Melodini Henryi 12 parts, Herba Ainsliaeae Glabrae 12 parts, Placenta Hominis 12 parts, 8 parts, Radix Glycyrrhizae.
CN201310467243.1A 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition Expired - Fee Related CN103494904B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310467243.1A CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310467243.1A CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Publications (2)

Publication Number Publication Date
CN103494904A CN103494904A (en) 2014-01-08
CN103494904B true CN103494904B (en) 2015-07-29

Family

ID=49860227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310467243.1A Expired - Fee Related CN103494904B (en) 2013-09-23 2013-09-23 One treats neurasthenic Chinese medicine composition

Country Status (1)

Country Link
CN (1) CN103494904B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1083719A (en) * 1993-06-09 1994-03-16 苏鉴 Relieving mental strain and helping sleep Chinese patent medicine and preparation method thereof
USPP19942P2 (en) * 2008-03-12 2009-04-21 Gurjit Sidhu Sarcococca plant named ‘Sarsid 1’
CN101780159B (en) * 2010-03-08 2011-08-10 韩凤珍 Preparation method of traditional Chinese medicine for treating insomnia with deficiency of both heart-qi and gallbladder-qi

Also Published As

Publication number Publication date
CN103494904A (en) 2014-01-08

Similar Documents

Publication Publication Date Title
CN101264275B (en) Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis
CN103860912B (en) One treats neurasthenic Chinese medicine composition
CN105194631B (en) Treat the Chinese medicine preparation of depression
CN103705705A (en) Traditional Chinese medicine composition for treating polymyositis
CN103800888B (en) A kind of Chinese medicine composition treating neurasthenia
CN103948708B (en) A kind of Chinese medicine for the treatment of restless legs syndrome
CN103495019B (en) A kind of tranquilizing by nourishing the heart Chinese medicine preparation and preparation method thereof
CN104225450A (en) Traditional Chinese medicine for treating depression
CN103550688B (en) A kind of Chinese medicine composition for the treatment of cardiopalmus
CN102687967A (en) Hypertension medicinal pillow
CN104771652A (en) Vertigo treating traditional Chinese medicine composition
CN103494904B (en) One treats neurasthenic Chinese medicine composition
CN105535849A (en) Traditional Chinese medicine for treating liver depression insomnia
CN104524235A (en) Traditional Chinese medicine composition for treating cardiac neurosis
CN104606650A (en) Traditional Chinese medicine composition treating insomnia
CN104547642A (en) Tradtional Chinese medicine composition for treating female fibromyalgia syndromes
CN103610856A (en) Traditional Chinese medicine preparation for treating neurasthenia
CN104056206A (en) Refreshing, depression-resolving and tranquilizing preparation
CN101653495B (en) Chinese traditional medicine for curing insomnia
CN105943753A (en) Traditional Chinese medicinal composition for preventing and treating chronic fatigue syndrome
CN104258176A (en) Traditional Chinese medicine preparation for treating vegetative nerve functional disorder
CN105833199A (en) Traditional Chinese medicine composition for treating hysteria
CN104524090A (en) Traditional Chinese medicine preparation for treating sequelae of head injury
CN105288149A (en) Traditional Chinese medicine composition for treating neurasthenia
CN104940790A (en) Traditional Chinese medicine for treating psychoneurosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150729

Termination date: 20150923

EXPY Termination of patent right or utility model